M&A Deal Summary |
|
|---|---|
| Date | 2012-01-31 |
| Target | Grupo Farmaceutico Biotoscana |
| Sector | Life Science |
| Buyer(s) |
Advent International
EW Healthcare Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1984 |
| PE ASSETS | 91.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 196 of 353 |
| Sector: Life Science M&A | 10 of 22 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 125 of 156 |
| Country: Uruguay M&A | 3 of 3 |
| Year: 2012 M&A | 1 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-31 |
Five Below
Philadelphia, Pennsylvania, United States Five Below is a retailer of extreme-value merchandise, all priced between $1.00 and $5.00, to the teen and preteen market. Five Below was founded in 2002 and is based in Philadelphia, Pennsylvania. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-02-17 |
TransUnion
Chicago, Illinois, United States TransUnion is a global provider of information and risk management solutions. TransUnion provides these solutions to businesses across multiple industries and to individual consumers. TransUnion technology and services enable businesses to make informed credit granting, risk management, underwriting, fraud protection and customer acquisition decisions by delivering data that's integrated with analytics and decisioning capabilities. TransUnion was founded in 1968 and is based in Chicago, Illinois. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 44 of 59 |
| Sector: Life Science M&A | 14 of 20 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 4 of 7 |
| Country: Uruguay M&A | 1 of 1 |
| Year: 2012 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-12-29 |
Abiomed
Danvers, Massachusetts, United States Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-04-30 |
EUSA Pharma
Langhorne, Pennsylvania, United States EUSA Pharma is a trans-Atlantic specialty pharmaceutical company focused on oncology and critical care. EUSA intends to build a portfolio of products that are on the market or in late-stage clinical trials through acquisitions and in-licensing. The company has a sales and marketing organization and commercial infrastructure in the US and all major European countries. |
Sell | $680M |
